Median Effective Dose of Dexmedetomidine Inducing Bradycardia in Elderly Patients Determined by Up-and-Down Sequential Allocation Method

Abstract

Purpose: When dexmedetomidine is used in elderly patients, high incidence of bradycardia is reported. Given age-related physiological changes in this population, it is necessary to know the safety margin between the loading dose of dexmedetomidine and bradycardia. Therefore, we conducted this study to investigate the median effective dose (ED50) of dexmedetomidine causing bradycardia in elderly patients. Methods: Thirty patients with ages over 65 years undergoing elective general surgery were enrolled. The Dixon and Massay sequential method were applied to determine the loading dose of dexmedetomidine, starting from 1.0 µg/kg. The dose for the follow-up subjects increased or decreased according to the geometric sequence with the common ratio 1.2, based on the 'negative' or 'positive' response of the previous subject. Positive mean that the subject developed bradycardia during the test. Hemodynamic data including heart rate and systolic blood pressure were recorded. The level of sedation was assessed with the Observer Assessment of Alertness and Sedation Scale (OAA/S). Results: Bradycardia occurred in 13 patients (43.3%). The ED50 of dexmedetomidine causing bradycardia was 1.97 µg/kg (95% CI, 1.53-2.53 µg/kg). OAA/S scores at 10 min after the beginning of the dexmedetomidine infusion and 10 min after the termination of dexmedetomidine administration showed no significant differences between the positive and negative groups (P > 0.05). Conclusion:The ED50 of dexmedetomidine causing bradycardia in our cohort was higher than clinical recommended dose. A higher loading dose appears acceptable for a faster onset of sedation under careful hemodynamic monitoring. Trial registration: ChiCTR 15006368.

Remimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases

“…Remimazolam is approved for general anesthesia in Japan, South Korea, and the European Union. The dosing for general anesthesia differs between those countries that have approval, ranging from an anesthesia infusion rate of no more than 12 mg/kg/h for induction, with a maintenance infusion of 1–2 mg/kg/h [ 10 , 11 , 12 , 13 , 14 , 15 ].…”

Evaluation of the Relationship between Baseline Autonomic Tone and Haemodynamic Effects of Dexmedetomidine

“…In another study that included elderly patients, bradycardia occurred in 43% of patients. Bradycardia was defined as a HR below 50 beats min −1 [ 25 ]. We decided not to use a single cut-off value for bradycardia, but a decrease by 20% from the pre-drug value.…”

Taming Postoperative Delirium with Dexmedetomidine: A Review of the Therapeutic Agent’s Neuroprotective Effects following Surgery

“…The selectivity for alpha 2 -adrenergic receptors is minimized at high doses or with rapid intravenous administration [45]. To minimize adverse effects from high doses or rapid administration, dexmedetomidine should be introduced over a prolonged bolus, around 10 min, and should be titrated carefully to a patient's individual hemodynamic measures, especially heart rate and blood pressure [47].…”